Company Overview - Zhejiang Dayang Biological Technology Group Co., Ltd. is located in Hangzhou, Zhejiang Province, and was established on January 1, 1976. The company was listed on October 26, 2020. Its main business involves the production and sales of chemical raw materials, including inorganic salts and veterinary raw materials [2]. Financial Performance - As of June 30, the company reported a revenue of 499 million yuan for the first half of 2025, representing a year-on-year growth of 14.20%. The net profit attributable to the parent company was 50.51 million yuan, showing a significant increase of 60.66% year-on-year [2]. - The company has distributed a total of 168 million yuan in dividends since its A-share listing, with 97.57 million yuan distributed over the past three years [3]. Stock Performance - Year-to-date, the stock price of Dayang Biological has increased by 79.60%. However, it has experienced a decline of 4.05% over the last five trading days and 5.43% over the last 20 days. In contrast, the stock has risen by 29.06% over the past 60 days [2]. - As of September 22, the stock price was 32.91 yuan per share, with a market capitalization of 2.764 billion yuan. The trading volume was 45.52 million yuan, with a turnover rate of 1.97% [1]. Shareholder Information - As of June 30, the number of shareholders increased to 14,200, reflecting a growth of 58.33%. The average number of circulating shares per shareholder decreased by 35.82% to 4,954 shares [2]. Business Segmentation - The company's main business revenue composition includes: 69.91% from inorganic salt products, 18.35% from veterinary raw materials, 7.46% from fluorine chemical products, and 4.28% from other products [2]. - Dayang Biological is classified under the Shenwan industry as basic chemicals - chemical raw materials - inorganic salts, and is associated with concepts such as fertilizers, biopesticides, fluorine chemicals, share buybacks, and synthetic biology [2].

Company Overview - Sinochem International is located in the China (Shanghai) Free Trade Zone and was established on December 14, 1998, with its listing date on March 1, 2000. The company specializes in fine chemical businesses, including chemical new materials and agricultural chemicals [2] - The revenue composition of Sinochem International includes: Other 31.04%, Chemical Material Marketing 29.68%, High-Performance Materials 17.53%, Basic Raw Materials and Intermediates 14.48%, and Polymer Additives 7.28% [2] - As of June 30, the number of shareholders of Sinochem International was 70,600, an increase of 1.76% from the previous period, with an average of 50,797 circulating shares per person, a decrease of 1.73% [2] Financial Performance - For the first half of 2025, Sinochem International achieved operating revenue of 24.353 billion yuan, a year-on-year decrease of 5.83%. The net profit attributable to the parent company was -886 million yuan, a year-on-year decrease of 7.29194 billion yuan [2] - The company has cumulatively distributed 5.533 billion yuan in dividends since its A-share listing, with 539 million yuan distributed in the last three years [3] Stock Performance - On September 18, Sinochem International's stock price fell by 2.02%, trading at 4.37 yuan per share, with a total market capitalization of 15.682 billion yuan [1] - Year-to-date, the stock price has increased by 8.71%, with a decline of 4.17% over the last five trading days, a rise of 3.80% over the last 20 days, and an increase of 17.79% over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on July 29, where it recorded a net purchase of 546.943 million yuan [1]

Company Overview - Zhejiang Dayang Biological Technology Group Co., Ltd. is located in Dayang Town, Jiande City, Hangzhou, Zhejiang Province, and was established on January 1, 1976. The company was listed on October 26, 2020. Its main business involves the production and sales of chemical raw materials, including inorganic salts and veterinary raw materials [1][2]. Financial Performance - As of June 30, the number of shareholders for Dayang Biological increased by 58.33% to 14,200, while the average circulating shares per person decreased by 35.82% to 4,954 shares [2]. - For the first half of 2025, Dayang Biological achieved operating revenue of 499 million yuan, representing a year-on-year growth of 14.20%. The net profit attributable to the parent company was 50.51 million yuan, reflecting a year-on-year increase of 60.66% [2]. Stock Performance - On September 18, Dayang Biological's stock price fell by 2.00% to 34.28 yuan per share, with a trading volume of 21.62 million yuan and a turnover rate of 0.90%. The total market capitalization is 2.88 billion yuan [1]. - Year-to-date, Dayang Biological's stock price has increased by 87.08%. Over the past five trading days, the stock has decreased by 2.39%, while it has increased by 0.62% over the past 20 days and by 36.68% over the past 60 days [1]. Business Segmentation - The main revenue composition of Dayang Biological includes: inorganic salt products (69.91%), veterinary raw materials (18.35%), fluorine chemical products (7.46%), and other products (4.28%) [1]. - The company belongs to the Shenwan industry category of basic chemicals, specifically chemical raw materials and inorganic salts. It is associated with several concept sectors, including fertilizers, fluorine chemicals, biopesticides, share buybacks, and stock transfers [1]. Dividend Distribution - Since its A-share listing, Dayang Biological has distributed a total of 168 million yuan in dividends. Over the past three years, the cumulative dividend payout has been 97.57 million yuan [3].

Core Viewpoint - Yangnong Chemical's stock has experienced fluctuations, with a recent decline of 2.00% and a year-to-date increase of 26.65% [1] Financial Performance - For the first half of 2025, Yangnong Chemical reported revenue of 6.234 billion yuan, a year-on-year increase of 9.38%, and a net profit attributable to shareholders of 806 million yuan, up 5.60% [2] - Cumulative cash dividends since the company's A-share listing amount to 2.735 billion yuan, with 1.04 billion yuan distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 6.01% to 18,100, while the average circulating shares per person increased by 6.40% to 22,271 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 754,800 shares to 16.2928 million shares [3]

Company Overview - Zhejiang Dayang Biological Technology Group Co., Ltd. is located in Jiande City, Hangzhou, Zhejiang Province, and was established on January 1, 1976. The company was listed on October 26, 2020. [2] - The main business involves the production and sales of chemical raw materials, including inorganic salts and veterinary raw materials. The revenue composition is as follows: inorganic salt products 69.91%, veterinary raw materials 18.35%, fluorine chemical products 7.46%, and other products 4.28%. [2] Stock Performance - As of September 16, the stock price of Dayang Biological fell by 2.10% to 33.58 CNY per share, with a trading volume of 42.01 million CNY and a turnover rate of 1.78%. The total market capitalization is 2.821 billion CNY. [1] - Year-to-date, the stock price has increased by 83.26%, but it has decreased by 7.11% in the last five trading days. Over the last 20 days, the stock price has risen by 0.33%, and over the last 60 days, it has increased by 31.22%. [2] Financial Performance - For the first half of 2025, Dayang Biological achieved operating revenue of 499 million CNY, representing a year-on-year growth of 14.20%. The net profit attributable to the parent company was 50.51 million CNY, with a year-on-year increase of 60.66%. [2] - The company has distributed a total of 168 million CNY in dividends since its A-share listing, with cumulative distributions of 97.57 million CNY over the past three years. [3] Shareholder Information - As of June 30, the number of shareholders reached 14,200, an increase of 58.33% compared to the previous period. The average number of circulating shares per person is 4,954, which is a decrease of 35.82% from the previous period. [2] Industry Classification - Dayang Biological is classified under the Shenwan industry category of basic chemicals, specifically in chemical raw materials and inorganic salts. The company is associated with several concept sectors, including fertilizers, fluorine chemicals, biological pesticides, and share buybacks. [2]

Company Overview - Lianhua Technology Co., Ltd. is located in Taizhou, Zhejiang Province, established on September 14, 1998, and listed on June 19, 2008 [2] - The company operates in three main business segments: pesticides, pharmaceuticals, and functional chemicals, with revenue contributions of 54.03%, 32.32%, 8.42%, and 4.88% from equipment and engineering services, respectively [2] - As of June 30, 2025, the number of shareholders increased by 88.92% to 72,300, while the average circulating shares per person decreased by 47.07% to 12,533 shares [2] Financial Performance - For the first half of 2025, Lianhua Technology achieved a revenue of 3.15 billion yuan, representing a year-on-year growth of 5.76%, and a net profit attributable to shareholders of 224 million yuan, a significant increase of 1481.94% [2] - The company has distributed a total of 960 million yuan in dividends since its A-share listing, with 129 million yuan distributed over the past three years [3] Stock Market Activity - On September 16, Lianhua Technology's stock price fell by 2.03% to 11.12 yuan per share, with a trading volume of 182 million yuan and a turnover rate of 1.79%, resulting in a total market capitalization of 10.134 billion yuan [1] - Year-to-date, the stock price has increased by 102.55%, but it has seen a decline of 1.77% over the last five trading days and a drop of 17.38% over the past 60 days [1] - The company has appeared on the "Dragon and Tiger List" nine times this year, with the most recent appearance on June 25, where it recorded a net buy of -46.854 million yuan [1]

Core Viewpoint - Yangnong Chemical's stock has experienced fluctuations, with a year-to-date increase of 28.82% but a recent decline of 4.50% over the past five trading days [1] Financial Performance - For the first half of 2025, Yangnong Chemical reported revenue of 6.234 billion yuan, a year-on-year increase of 9.38%, and a net profit attributable to shareholders of 806 million yuan, up 5.60% [2] - Cumulative cash dividends since the company's A-share listing amount to 2.735 billion yuan, with 1.04 billion yuan distributed over the past three years [3] Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 6.01% to 18,100, while the average circulating shares per person increased by 6.40% to 22,271 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 754,800 shares to 16.2928 million shares [3]

Company Overview - Lianhua Technology Co., Ltd. is located in Taizhou, Zhejiang Province, established on September 14, 1998, and listed on June 19, 2008 [2] - The company operates in three main sectors: pesticides, pharmaceuticals, and functional chemicals, with revenue contributions of 54.03%, 32.32%, 8.42%, and 4.88% from equipment and engineering services, respectively [2] - As of June 30, the number of shareholders increased to 72,300, with an average of 12,533 circulating shares per person, a decrease of 47.07% [2] Financial Performance - For the first half of 2025, Lianhua Technology achieved revenue of 3.15 billion yuan, a year-on-year increase of 5.76%, and a net profit attributable to shareholders of 224 million yuan, a significant increase of 1481.94% [2] - The company has distributed a total of 960 million yuan in dividends since its A-share listing, with 129 million yuan distributed in the last three years [3] Stock Performance - On September 15, Lianhua Technology's stock price rose by 2.13% to 11.52 yuan per share, with a trading volume of 407 million yuan and a turnover rate of 3.98%, bringing the total market capitalization to 10.499 billion yuan [1] - The stock has increased by 109.84% year-to-date, with a slight increase of 0.44% over the last five trading days and a 12.94% increase over the last 20 days, while it has decreased by 10.90% over the last 60 days [1] - The company has appeared on the trading leaderboard nine times this year, with the most recent appearance on June 25, where it recorded a net buy of -46.85 million yuan [1] Shareholding Structure - As of June 30, the second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 40.3583 million shares, an increase of 21.3384 million shares from the previous period [3] - The fund "Noan Pioneer Mixed A" has exited the list of the top ten circulating shareholders [3]

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a 66.39% increase, and the company is actively engaging in its core business of industrial biocides and semiconductor materials [1][2]. Group 1: Stock Performance - As of September 12, Baiao Chemical's stock price reached 25.73 CNY per share, with a market capitalization of 18.171 billion CNY [1]. - The stock has experienced a 4.64% increase over the last five trading days, a 17.01% increase over the last 20 days, and a 30.41% increase over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on August 28 [1]. Group 2: Financial Performance - For the first half of 2025, Baiao Chemical reported a revenue of 749 million CNY, representing a year-on-year growth of 28.42% [2]. - The net profit attributable to shareholders for the same period was 91.7885 million CNY, which is a decrease of 44.22% year-on-year [2]. Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders increased by 20.58% to 21,300, with an average of 33,173 circulating shares per shareholder, up by 16.11% [2]. - Since its A-share listing, Baiao Chemical has distributed a total of 1.224 billion CNY in dividends, with 722 million CNY distributed over the last three years [3]. - Notable new institutional shareholders include the Southern CSI 1000 ETF and Hong Kong Central Clearing Limited, holding 3.2711 million shares and 2.4283 million shares, respectively [3].

Company Overview - Zhejiang Dayang Biological Technology Group Co., Ltd. is located in Dayang Town, Jiande City, Hangzhou, Zhejiang Province, and was established on January 1, 1976. The company was listed on October 26, 2020 [1] - The main business involves the production and sales of chemical raw materials, including inorganic salts and veterinary raw materials. The revenue composition is as follows: inorganic salt products 69.91%, veterinary raw materials 18.35%, fluorine-containing chemicals 7.46%, and other products 4.28% [1] Financial Performance - As of June 30, the number of shareholders increased to 14,200, a rise of 58.33% compared to the previous period. The average circulating shares per person decreased by 35.82% to 4,954 shares [2] - For the first half of 2025, the company achieved operating revenue of 499 million yuan, representing a year-on-year growth of 14.20%. The net profit attributable to the parent company was 50.51 million yuan, up 60.66% year-on-year [2] Stock Performance - On September 12, the stock price of Dayang Biological fell by 2.11% to 34.38 yuan per share, with a trading volume of 30.92 million yuan and a turnover rate of 1.28%. The total market capitalization is 2.888 billion yuan [1] - Year-to-date, the stock price has increased by 87.62%, with a decline of 1.72% over the last five trading days, a rise of 6.67% over the last 20 days, and an increase of 23.18% over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on June 16 [1] Dividend Information - Since its A-share listing, Dayang Biological has distributed a total of 168 million yuan in dividends, with 97.57 million yuan distributed over the past three years [3]